# Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

> **NCT04180007** · PHASE2 · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Thyroid
- Metastasis
- Apatinib

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT04180007
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-10
- **Primary completion:** 2020-04-10
- **Final completion:** 2020-05-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04180007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04180007, "Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04180007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*